Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Actelion, Syngenta takeovers set to shake up Swiss SMI index

Stock MarketsJan 31, 2017 08:30AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. The company's logo is seen at the headquarters of Swiss biotech company Actelion in Allschwil

By Rupert Pretterklieber

ZURICH (Reuters) - The looming foreign takeovers of biotech group Actelion and agrichemicals firm Syngenta look set to trigger the biggest shake-up in the Swiss blue-chip SMI index (SSMI) in years just as passive investing makes membership increasingly important.

Analysts say specialty chemicals group Lonza (S:LONN) may be set to join the Swiss club of the 20 best capitalized and most liquid shares, whose ranks could be thinned even further by the time that the next review takes place in June, analysts say.

"It is pretty clear that under the current selection list by the Swiss exchange, Lonza could be taken into the SMI," said Thomas Kuehne, fund manager at Liechtensteinische Landesbank.

He noted Lonza's market capitalization of around 10 billion Swiss francs ($10.06 billion), which could increase thanks to its $5.5 billion acquisition of U.S. group Capsugel.

Lonza is now ranked 21st by market capitalization. SMI components have a combined market value above 1 trillion francs.

Construction chemicals specialist Sika (S:SIK) and hearing aid maker Sonova (S:SOON) are also in the hunt for an SMI spot after boosting growth with acquisitions.

"Sika is in second place" after Lonza, said Eric Chassot, portfolio manager at Banque Cantonale Vaudoise, while Kuehne saw them battling for that role.

"Sonova has a bit more trading volume, while Sika has a higher free float market capitalization," he said.

Joining the SMI is more than just a matter of prestige.

Exchange-traded funds that build portfolios mirroring the composition of stock indices -- thus cutting costs for investors -- have seen a massive boost in popularity, increasing the importance of belonging to a high-profile index.

U.S. healthcare giant Johnson & Johnson (N:JNJ) plans to buy Actelion (S:ATLN) in a $30 billion all-cash deal while state-owned Chinese firm ChemChina has agreed a $43 billion offer for Syngenta (S:SYNN).

The SIX Swiss Exchange will decide in June on any modifications that would then take effect in September after Eurex derivatives contracts expire. But out-of-schedule changes are also possible in the wake of unusual events such as mergers or new listings.


Market experts said the new share set to be created later this year by the spinoff of Credit Suisse's (S:CSGN) Swiss banking unit had an outside chance of an SMI spot.

Chassot said this hinged on details of the flotation, which Credit Suisse has said could list 20 to 30 percent of the unit. Kuehne thought the placement would be too small to heave the stock into the SMI.

The SIX Exchange said having two shares from the same group in the SMI was not ruled out.

In any event, more than two slots in the SMI may open up this year for the first time since 2009.

Shares in private bank Julius Baer (S:BAER) and insurer Swiss Life (S:SLHN) are on the brink of dropping out of the index after Baer shares dipped to 21st on the volume criterion and Swiss Life's market value slipped to 23rd.

"We don't speculate about which share will join or drop out" of an index, said Serkan Batir of market leader BlackRock. "We will await the official announcement from the exchange and then see what we need to do."

In many years there are no or only one change to the SMI, only half of whose constituents were among the founding members of 1988 and often with a new corporate name.

Actelion, Syngenta takeovers set to shake up Swiss SMI index

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email